Related Experiment Video
Updated: Feb 6, 2026

A Porcine Corneal Endothelial Organ Culture Model Using Split Corneal Buttons
Published on: October 6, 2019
Perspective of Future Potent Therapies for Fuchs Endothelial Corneal Dystrophy
Naoki Okumura1, Ryousuke Hayashi1, Noriko Koizumi1
1Department of Biomedical Engineering, Faculty of Life and Medical Sciences,Doshisha University,Kyotanabe,Japan.
Background:
Fuchs Endothelial Corneal Dystrophy (FECD) is a progressive disease that affects the corneal endothelium in both eyes. Recent studies have identified a novel genetic basis for FECD, and basic research findings have provided evidence for its underlying pathophysiology. Since its first description by Ernst Fuchs in 1910, the only therapeutic choice has been corneal transplantation using donor corneas. However, accumulating evidence suggests that a change in this "rule" may be imminent.
Conclusions:
This article reviews the current knowledge of the genetics and pathophysiology of FECD, and it introduces some potent therapeutic modalities that show promise as new treatments for this disorder.
Insights
Fuchs Endothelial Corneal Dystrophy (FECD) is a progressive eye disease. New research into its genetic basis and pathophysiology suggests promising new treatments beyond corneal transplantation may soon be available.
Area of Science:
- Ophthalmology
- Genetics
- Molecular Biology
Background:
- Fuchs Endothelial Corneal Dystrophy (FECD) is a progressive bilateral disease affecting the corneal endothelium.
- Recent research has uncovered a novel genetic basis and elucidated the pathophysiology of FECD.
- Historically, corneal transplantation has been the sole treatment option for FECD.
Purpose of the Study:
- To review current knowledge on FECD genetics and pathophysiology.
- To introduce emerging therapeutic modalities for FECD.
Main Methods:
- Review of recent genetic studies.
- Analysis of basic research findings on FECD pathophysiology.
- Survey of novel therapeutic strategies.
Main Results:
- Identification of a novel genetic basis for FECD.
- Evidence supporting specific pathophysiological mechanisms.
- Emergence of promising new therapeutic targets.
Conclusions:
- Current understanding of FECD genetics and pathophysiology has advanced significantly.
- Novel therapeutic approaches show potential to alter FECD treatment paradigms.
Related Concept Videos
Psychodynamic Perspectives on Personality
Psychodynamic theorists argue that unconscious...
Satellite Stem Cells and Muscular Dystrophy
Criticisms of the Evolutionary Perspective
Evolutionary psychology provides one explanation for these findings, suggesting...
The Behavioral Perspective on Personality
Social Cognitive Perspective on Personality
Gene Therapy

